安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Mallinckrodt - Home | Introducing Keenova and Par Health
Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products Stay tuned for updates
- Mallinckrodt - Wikipedia
Mallinckrodt Mallinckrodt Pharmaceuticals plc is an Irish-American manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents [2] In 2017, it had 5,500 employees and sales of $3 2 billion, of which $2 9 billion was from the U S healthcare system [3]
- Mallinckrodt, Endo become Keenova following generics spinoff
Some three months after merging, Mallinckrodt and Endo have successfully spun off their combined sterile injectables and generics businesses
- Par Health Completes Spin-Off from Mallinckrodt, Creating an . . .
LOUIS, Nov 10, 2025 PRNewswire -- Par Health, Inc ("Par Health" or the "Company") today announced that it has successfully completed its previously announced spin-off from Mallinckrodt plc
- Mallinckrodt, Endo Launch as Keenova Therapeutics Following Merger . . .
Mallinckrodt and Endo, two specialty pharma and generics companies, have announced the next step in their merger plan, first announced in March 2025, and completed on August 1, 2025 The…
- Mallinckrodt Pharmaceuticals - Listening for Needs. Delivering Solutions
About Us Solving complex challenges with a diverse product portfolio Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products
- Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical Company . . .
As a global specialty pharmaceutical company, Mallinckrodt has been making the complex simple for more than 150 years Visit the website to learn more
- Mallinckrodt to take over Endo in deal valued at $6. 7 billion
Ireland’s Mallinckrodt will buy U S drugmaker Endo in a cash-and-stock deal valued at $6 7 billion The companies said Thursday that Endo shareholders will receive a total of $80 million in cash and own nearly 50% of the combined company
|
|
|